Roth MKM analyst Matt Koranda raised the firm’s price target on Cadre to $30 from $28 and keeps a Buy rating on the shares. The company’s Q2 results featured “modest” sales growth but robust margin expansion and incremental pull-through on adjusted EBITDA, and the management highlighted a maturing M&A funnel, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CDRE: